Free tool
FAERS Monitor: Tpn Electrolytes In Plastic Container
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 018895 or its brand name (Tpn Electrolytes In Plastic Container, Calcium Chloride, Magnesium Chloride, Potassium Chloride, Sodium Acetate, Sodium Chloride). Reports on generic versions are filed under their own applications.
Reports
35
Serious
29
83% of reports
Hospitalization
16
Death reported
6
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- nausea4
- vomiting4
- urticaria3
- cough2
- covid-192
- death2
- fungaemia2
- hepatic failure2
- pruritus2
- sepsis2
- urinary tract infection2
- abdominal abscess1
- abdominal pain1
- abdominal pain upper1
- acquired aminoaciduria1
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2005 | 1 |
| 2010 | 1 |
| 2012 | 1 |
| 2014 | 1 |
| 2015 | 3 |
| 2018 | 3 |
| 2019 | 4 |
| 2020 | 2 |
| 2021 | 4 |
| 2022 | 5 |
| 2023 | 3 |
| 2024 | 3 |
| 2025 | 1 |
| 2026 | 2 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,054,124 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| acquired aminoaciduria | 1 | 15038.7 | 2125.8 | 3,667 |
| fungaemia | 2 | 764.8 | 198.9 | 856 |
| abdominal abscess | 1 | 136.0 | 19.7 | 33 |
| hepatic failure | 2 | 39.9 | 10.4 | 42 |
| sepsis | 2 | 10.8 | 2.8 | 9 |
| urticariaSignal | 3 | 10.8 | 3.6 | 18 |
| urinary tract infection | 2 | 7.0 | 1.8 | 5 |
| covid-19 | 2 | 6.9 | 1.8 | 5 |
| vomitingSignal | 4 | 5.1 | 2.0 | 10 |
| cough | 2 | 4.3 | 1.1 | 2 |
| pruritus | 2 | 3.1 | 0.8 | 1 |
| nausea | 4 | 3.0 | 1.2 | 4 |
| abdominal pain upper | 1 | 2.9 | 0.4 | 0 |
| abdominal pain | 1 | 2.6 | 0.4 | 0 |
| death | 2 | 1.4 | 0.4 | 0 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.